Evidence map›Paper›PMID 38387031›Full record

ArticleThe oncologist2024

Palliative Care Interventions and End-of-Life Care for Patients with Metastatic Breast Cancer: A Multicentre Analysis.

Elisabeth Lucchi, Frédérique Berger, Maude Milder, Jean-Marie Commer, Sophie Morin, Geraldine Capodano, Muriel Thomaso, Anne Fogliarini, Nathalie Bremaud, Aline Henry and 3 more

Abstract readMulticenter Study
In one paragraph

Article in The oncologist, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Elisabeth LucchiSupportive and Palliative Care Department, Institut Curie, Paris, France.
Frédérique BergerBiostatistics Department, Institut Curie, Paris, France.
Maude MilderBiostatistics Department, Institut Curie, Paris, France.
Jean-Marie CommerSupportive and Palliative Care Department, Institut de Cancerologie de Loire, Anger, France.
Sophie MorinSupportive and Palliative Care Department, Institut Bergonie, Paris, France.
Geraldine CapodanoSupportive and Palliative Care Department, Institut Paoli-Calmette, Marseille, France.
Muriel ThomasoSupportive and Palliative Care Department, Institut de Cancerologie de Montpellier, Montpellier, France.
Anne FogliariniSupportive and Palliative Care Department, Centre Lacassagne, Nice, France.
Nathalie BremaudSupportive and Palliative Care Department, Centre Georges François Leclerc, Dijon, France.
Aline HenrySupportive and Palliative Care Department, Centre Alexis Vautrin, Nancy, France.
Benedicte MastroianniSupportive and Palliative Care Department, Centre Léon Berard, Lyon, France.
Gisele ChvetzoffSupportive and Palliative Care Department, Centre Léon Berard, Lyon, France.
Carole BouleucSupportive and Palliative Care Department, Institut Curie, Paris, France.ORCID 0000-0003-0451-7720

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to describe the implementation of integrated palliative care (PC) and the intensity of care in the last 3 months before death for patients with metastatic breast cancer. MATERIALS AND

methodsWe conducted a multicentric study of all adult patients with metastatic breast cancer who died over a 4-month period. Complete data were collected and checked from clinical records, including PC interventions and criteria regarding EOL care aggressiveness.

resultsA total of 340 decedent patients from 12 comprehensive cancer centres in France were included in the study. Sixty-five percent met the PC team with a median time of 39 days between the first intervention and death. In the last month before death, 11.5% received chemotherapy, the frequency of admission to intensive care unit was 2.4%, and 83% experienced acute hospitalization. The place of death was home for 16.7%, hospitalization for 63.3%, PC unit for 20%. Univariate and multivariate analyses showed factors independently associated with a higher frequency of chemotherapy in the last month before death: having a dependent person at home, meeting for the first time with a PC team < 30 days before death, and time between the first metastasis and death below the median.

conclusionPC team integration was frequent and late for patients with metastatic breast cancer. However, PC intervention > 30 days is associated with less chemotherapy in the last month before death. Further studies are needed to better understand how to implement a more effective mode of PC integration for patients with metastatic breast cancer.

Indexed as

Breast NeoplasmsPalliative CareTerminal CareAdultAgedAged, 80 and overFemaleFranceHumansMiddle AgedNeoplasm Metastasisend-of-life caremetastatic breast cancerpalliative care

Identifiers

PMID38387031
PMCPMC11067792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.